CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Grant or award Director acquired 1,155 shares (grant or award)
- 4 Grant or award Director acquired 1,155 shares (grant or award)
- 4 Grant or award Director acquired 1,905 shares (grant or award)
- 4 Grant or award Director acquired 1,155 shares (grant or award)
- 4 Grant or award Director acquired 1,155 shares (grant or award)
- 4 Grant or award Director acquired 1,155 shares (grant or award)
- 4 Grant or award Director acquired 1,155 shares (grant or award)
- 4 Grant or award Director acquired 1,155 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes EVP, Research and Development gave up 960 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 658 shares (to pay taxes)
- 4 Open-market buy Director bought 118,342 shares at an average $229.94 ($27,211,824)
- 4 Open-market buy Chief Executive Officer bought 4,351 shares at $231.48 ($1,007,169)
- 4 Open-market sale Director sold 6,114 shares at $328.55 ($2,008,755)
- 4 Shares withheld for taxes EVP Pharmaceutical Oper & Tech gave up 658 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Chief Legal Officer & Sec. gave up 4,109 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 739 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,340 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 586 shares (to pay taxes)
Page 18 of 86 · 1,714 filings